Internal Medicine · Houston, TX
NPI
1801835749
Since 2006
Specialty
Internal Medicine
Code 207R00000X
Group practices
3
Medicare group memberships
Hospitals
6
Hospital affiliations
4545 Post Oak Place Dr Ste 130
Houston, TX, 77027
Phone (713) 960-8008
Groups this clinician bills Medicare through
Medicare paid, 2024
$54K
691 services
Medicare patients, 2024
400
Average age 76
Drug cost, 2024
$1.3M
17,408 prescriptions
Company payments, 2025
$204
From 3 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Taso Mougouris was code 99233 (hospital e&m - subsequent), 279 times for 184 patients. In total Taso Mougouris billed 691 services in 12 codes, and Medicare paid $54K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2026-08-31.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99233 Hospital E&M - Subsequent | Facility | 279 | 184 | $89.74 | $25K |
| 99308 SNF E&M | Facility | 183 | 93 | $55.65 | $10K |
| 99239 Hospital Discharge Management | Facility | 62 | 61 | $86.25 | $5,348 |
| G0180 Physician or allowed practitioner certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians and | Office | 52 | 33 | $39.05 | $2,031 |
| 99223 Hospital E&M - Initial | Facility | 35 | 35 | $131.08 | $4,588 |
| 99232 Hospital E&M - Subsequent | Facility | 34 | 25 | $59.24 | $2,014 |
| 99349 Home E&M - New and Established | Office | 20 | 17 | $94.23 | $1,885 |
By year: 2022 $337K for 4,669 services; 2023 $169K for 2,237 services; 2024 $54K for 691 services.
Medicare prescription drug claims, 2024
In 2024, the drug Taso Mougouris prescribed most often to Medicare patients was Atorvastatin Calcium, with 922 prescriptions and refills. In total Taso Mougouris wrote 17,408 Medicare prescriptions that cost $1.3M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Atorvastatin Calcium Generic | 922 | 934 | 199 | $16K |
| Levothyroxine Sodium Generic | 634 | 648 | 112 | $7,977 |
| Furosemide Generic | 543 | 545 | 127 | $4,192 |
| Amlodipine Besylate Generic | 532 | 536 | 115 | $5,644 |
| Gabapentin Generic | 504 | 508 | 100 | $9,800 |
| Eliquis Apixaban | 483 | 489 | 86 | $162K |
| Metoprolol Tartrate Generic | 413 | 421 | 117 | $4,524 |
| Carvedilol Generic | 355 | 359 | 72 | $5,408 |
| Donepezil Hcl Generic | 344 | 352 | 66 | $6,825 |
| Losartan Potassium Generic | 333 | 335 | 83 | $4,748 |
| Trazodone Hcl Generic | 332 | 346 | 74 | $5,224 |
| Lisinopril Generic | 305 | 311 | 61 | $4,097 |
| Mirtazapine Generic | 294 | 296 | 69 | $7,038 |
| Potassium Chloride Generic | 270 | 272 | 62 | $9,292 |
| Sertraline Hcl Generic | 269 | 274 | 59 | $3,292 |
Brand drugs: 2,611 claims; generic drugs: 14,751 claims; opioid claims: 173.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Taso Mougouris $204 ($204 in general payments such as food, travel and fees) from 3 companies. The largest payer was Revance Therapeutics, Inc. with $149.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.